How to manage MDM (Medical Decision Making) treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 1, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Medical Decision Making (MDM) treatment management should prioritize a patient-centered approach, focusing on shared decision-making, individualized care plans, and ongoing monitoring and evaluation, as recommended by the most recent and highest quality study 1. To manage MDM treatment effectively, consider the following key elements:

  • Clearly document the number and complexity of problems addressed during the patient encounter, including established conditions, new problems, and any exacerbations.
  • Assess the data reviewed, including test results, records from other providers, and independent visualization of images or specimens.
  • Evaluate risk by considering the patient's diagnosis, comorbidities, and potential complications from management options.
  • Document the clinical reasoning process, explaining why specific treatments were chosen over alternatives.
  • Implement a standardized documentation template that captures all MDM elements while avoiding excessive copying and pasting. Some important considerations in MDM treatment management include:
  • The importance of shared decision-making, as emphasized in 1 and 1, which involves educating patients about their condition, symptoms, and treatment options, and encouraging them to participate in decision-making.
  • The need for individualized care plans, as recommended in 1 and 1, which take into account the patient's unique needs, preferences, and values.
  • The role of ongoing monitoring and evaluation, as highlighted in 1 and 1, which involves regularly reviewing the patient's condition, adjusting treatment plans as needed, and addressing any concerns or issues that arise. By prioritizing these elements and considerations, healthcare providers can ensure that MDM treatment management is patient-centered, effective, and supportive of high-quality care.

From the Research

Managing MDM (Medical Decision Making) Treatment

To manage MDM treatment, several factors need to be considered, including the patient's goals, life circumstances, and the potential burden of treatment.

  • Minimally disruptive medicine (MDM) is a patient-centered approach that prioritizes patients' goals for life and health while minimizing the disruption caused by healthcare on patients' lives 2.
  • This approach is particularly useful for patients with complex lives and multimorbidity, as it coordinates healthcare and community responses to improve outcomes, reduce treatment burden, and enable patients to pursue their life's hopes and dreams 2.

Patient-Centered Care

Patient-centered care is essential in managing MDM treatment.

  • It involves understanding the patient's perspective, values, and preferences, and incorporating them into the decision-making process.
  • By doing so, healthcare providers can develop personalized treatment plans that address the patient's unique needs and circumstances.

Reducing Treatment Burden

Reducing treatment burden is a critical aspect of managing MDM treatment.

  • This can be achieved by simplifying treatment regimens, reducing the number of medications, and minimizing the frequency of medical appointments.
  • Healthcare providers can also help patients navigate the healthcare system, access community resources, and develop self-care strategies to manage their condition effectively.

Coordinating Healthcare and Community Responses

Coordinating healthcare and community responses is vital in managing MDM treatment.

  • This involves collaborating with healthcare providers, community organizations, and social services to develop a comprehensive care plan that addresses the patient's physical, emotional, and social needs.
  • By working together, healthcare providers can ensure that patients receive seamless, high-quality care that is tailored to their unique needs and circumstances.

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What personnel may be included in the staff at a research site, such as Research Assistants (RAs), Therapists/Counselors, or the Principal Investigator (PI)?
What type of studies are conducted to examine the long-term safety of a drug after it has been approved for marketing by the Food and Drug Administration (FDA)?
Do Certificates of Confidentiality (CoC) increase enrollment in clinical trials by ensuring participant privacy?
In which situation is a Serious Adverse Event (SAE) not required to be reported to the National Institute on Drug Abuse (NIDA) or designee within 24 hours: A. The investigator considers the SAE unrelated to study intervention, B. The SAE is non-fatal and non-life-threatening, C. The SAE occurs in a behavioral study, D. The SAE occurs in a non-Investigational New Drug (IND) study, E. The SAE occurs in the post-treatment observation period, or F. None of the above?
Which statement is not true regarding cluster sampling?
How to manage a medical condition?
What is the most appropriate additional treatment for a patient with diabetes, significant proteinuria, and stage G3 chronic kidney disease, currently taking lisinopril (Angiotensin-Converting Enzyme inhibitor) and metformin (Biguanide)?
What is the best management approach for a pregnant patient taking ramipril (Angiotensin-Converting Enzyme (ACE) inhibitor) for hypertension?
What is the next best step for managing uncontrolled hypertension in a post-kidney transplant patient on carvedilol (beta blocker) 25mg twice daily (BID), nifedipine (calcium channel blocker) 60mg daily, and hydralazine (vasodilator) 50mg BID?
What is the most appropriate test to assess the prognosis of a patient with chronic kidney disease (CKD) and a history of diabetes and hypertension?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question